Response and Survival Benefit with Chemoimmunotherapy in Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma.
Document Type
Journal Article
Publication Date
6-22-2017
Journal
Hematological Oncology
DOI
10.1002/hon.2449
APA Citation
Beltran, B., Quiñones, P., Morales, D., Malaga, J., Chavez, J., Sotomayor, E., & Castillo, J. (2017). Response and Survival Benefit with Chemoimmunotherapy in Epstein-Barr Virus-Positive Diffuse Large B-cell Lymphoma.. Hematological Oncology, (). http://dx.doi.org/10.1002/hon.2449
Peer Reviewed
1
